GIPR Polyclonal Antibody

GIPR encodes Gastric inhibitory polypeptide receptor for gastric inhibitory polypeptide (GIP), which was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release in the presence of elevated glucose. Mice lacking GIPR exhibit higher blood glucose levels with impaired initial insulin response after oral glucose load. Defect in GIPR thus may contribute to the pathogenesis of diabetes.

The GIPR Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of the Gastric Inhibitory Polypeptide Receptor (GIPR) protein. This antibody is produced using a unique and rigorous process, ensuring high affinity and specificity towards the GIPR protein.

The GIPR Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated and proven to provide reliable and reproducible results across a wide range of sample types and species.

With its superior sensitivity, the GIPR Polyclonal Antibody enables the detection of low abundance GIPR protein levels, making it an ideal choice for both basic research and clinical studies. Its versatility allows for the investigation of GIPR expression patterns and localization in different tissues and cell types.

This antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and minimizing experimental variability. It is available in various sizes to accommodate different experimental needs. Each batch of the GIPR Polyclonal Antibody undergoes stringent quality control procedures to guarantee consistent performance and batch-to-batch reproducibility.

Choose the GIPR Polyclonal Antibody for its exceptional specificity, sensitivity, and reliability, and unlock new insights into the role of GIPR in various physiological and pathological processes.